214 related articles for article (PubMed ID: 24098480)
21. Cysteine mediated disulfide bond formation in RAGE V domain facilitates its functionally relevant dimerization.
Jangde N; Ray R; Sinha S; Rana K; Singh SK; Khandagale P; Acharya N; Rai V
Biochimie; 2018 Nov; 154():55-61. PubMed ID: 30076903
[TBL] [Abstract][Full Text] [Related]
22. The G82S polymorphism promotes glycosylation of the receptor for advanced glycation end products (RAGE) at asparagine 81: comparison of wild-type rage with the G82S polymorphic variant.
Park SJ; Kleffmann T; Hessian PA
J Biol Chem; 2011 Jun; 286(24):21384-92. PubMed ID: 21511948
[TBL] [Abstract][Full Text] [Related]
23. Signal Diversity of Receptor for Advanced Glycation End Products.
Sakaguchi M; Kinoshita R; Putranto EW; Ruma IMW; Sumardika IW; Youyi C; Tomonobu N; Yamamoto KI; Murata H
Acta Med Okayama; 2017 Dec; 71(6):459-465. PubMed ID: 29276218
[TBL] [Abstract][Full Text] [Related]
24. RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.
Donato R
Curr Mol Med; 2007 Dec; 7(8):711-24. PubMed ID: 18331229
[TBL] [Abstract][Full Text] [Related]
25. Hydrogen/deuterium exchange mass spectrometry for investigating protein-ligand interactions.
Garcia RA; Pantazatos D; Villarreal FJ
Assay Drug Dev Technol; 2004 Feb; 2(1):81-91. PubMed ID: 15090213
[TBL] [Abstract][Full Text] [Related]
26. The Trp triad within the V-domain of the receptor for advanced glycation end products modulates folding, stability and ligand binding.
Indurthi VSK; Jensen JL; Leclerc E; Sinha S; Colbert CL; Vetter SW
Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31912881
[TBL] [Abstract][Full Text] [Related]
27. Hydrogen/deuterium exchange reveals distinct agonist/partial agonist receptor dynamics within vitamin D receptor/retinoid X receptor heterodimer.
Zhang J; Chalmers MJ; Stayrook KR; Burris LL; Garcia-Ordonez RD; Pascal BD; Burris TP; Dodge JA; Griffin PR
Structure; 2010 Oct; 18(10):1332-41. PubMed ID: 20947021
[TBL] [Abstract][Full Text] [Related]
28. TIRAP, an adaptor protein for TLR2/4, transduces a signal from RAGE phosphorylated upon ligand binding.
Sakaguchi M; Murata H; Yamamoto K; Ono T; Sakaguchi Y; Motoyama A; Hibino T; Kataoka K; Huh NH
PLoS One; 2011; 6(8):e23132. PubMed ID: 21829704
[TBL] [Abstract][Full Text] [Related]
29. Dissection of conformational conversion events during prion amyloid fibril formation using hydrogen exchange and mass spectrometry.
Singh J; Udgaonkar JB
J Mol Biol; 2013 Sep; 425(18):3510-21. PubMed ID: 23811055
[TBL] [Abstract][Full Text] [Related]
30. RAGE: a multi-ligand receptor unveiling novel insights in health and disease.
Alexiou P; Chatzopoulou M; Pegklidou K; Demopoulos VJ
Curr Med Chem; 2010; 17(21):2232-52. PubMed ID: 20459381
[TBL] [Abstract][Full Text] [Related]
31. Hexameric calgranulin C (S100A12) binds to the receptor for advanced glycated end products (RAGE) using symmetric hydrophobic target-binding patches.
Xie J; Burz DS; He W; Bronstein IB; Lednev I; Shekhtman A
J Biol Chem; 2007 Feb; 282(6):4218-31. PubMed ID: 17158877
[TBL] [Abstract][Full Text] [Related]
32. Low glucose degradation product peritoneal dialysis regimen is associated with lower plasma EN-RAGE and HMGB-1 proinflammatory ligands of receptor for advanced glycation end products.
Opatrna S; Popperlova A; Kalousová M; Zima T
Ther Apher Dial; 2014 Jun; 18(3):309-16. PubMed ID: 24965297
[TBL] [Abstract][Full Text] [Related]
33. RAGE expression and NF-kappaB activation attenuated by extracellular domain of RAGE in human salivary gland cell line.
Chuong C; Katz J; Pauley KM; Bulosan M; Cha S
J Cell Physiol; 2009 Nov; 221(2):430-4. PubMed ID: 19591173
[TBL] [Abstract][Full Text] [Related]
34. Structural insights into calcium-bound S100P and the V domain of the RAGE complex.
Penumutchu SR; Chou RH; Yu C
PLoS One; 2014; 9(8):e103947. PubMed ID: 25084534
[TBL] [Abstract][Full Text] [Related]
35. Tranilast Blocks the Interaction between the Protein S100A11 and Receptor for Advanced Glycation End Products (RAGE) V Domain and Inhibits Cell Proliferation.
Huang YK; Chou RH; Yu C
J Biol Chem; 2016 Jul; 291(27):14300-14310. PubMed ID: 27226584
[TBL] [Abstract][Full Text] [Related]
36. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways.
Huttunen HJ; Fages C; Rauvala H
J Biol Chem; 1999 Jul; 274(28):19919-24. PubMed ID: 10391939
[TBL] [Abstract][Full Text] [Related]
37. [Role of the receptor for advanced glycation end products (RAGE) in inflammation].
Mosquera JA
Invest Clin; 2010 Jun; 51(2):257-68. PubMed ID: 20928981
[TBL] [Abstract][Full Text] [Related]
38. RAGE and RAGE ligands in cancer.
Logsdon CD; Fuentes MK; Huang EH; Arumugam T
Curr Mol Med; 2007 Dec; 7(8):777-89. PubMed ID: 18331236
[TBL] [Abstract][Full Text] [Related]
39. Influence of nonenzymatic posttranslational modifications on constitution, oligomerization and receptor binding of S100A12.
Augner K; Eichler J; Utz W; Pischetsrieder M
PLoS One; 2014; 9(11):e113418. PubMed ID: 25426955
[TBL] [Abstract][Full Text] [Related]
40. The biology of the receptor for advanced glycation end products and its ligands.
Schmidt AM; Yan SD; Yan SF; Stern DM
Biochim Biophys Acta; 2000 Dec; 1498(2-3):99-111. PubMed ID: 11108954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
